Sigma Lithium Corporation ("Sigma Lithium" or the "Company") (NASDAQ:SGML, TSXV:SGML, BVMF: S2GM34)))), a leading lithium producer dedicated to powering the next generation of electric
Fractyl Health, developing procedural and gene therapies for type 2 diabetes and obesity, filed an S-1 filing with the SEC on Thursday to raise up to $100 million in an initial public offering.
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are scheduled to trade publicly this week.